Article Versions Notes

Leone P, Solimando AG, Fasano R, Argentiero A, Malerba E, Buonavoglia A, Lupo LG, De Re V, Silvestris N, Racanelli V. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment. Vaccines. 2021; 9(5):532. https://doi.org/10.3390/vaccines9050532

Leone, Patrizia, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, and Vito Racanelli. 2021. "The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment" Vaccines 9, no. 5: 532. https://doi.org/10.3390/vaccines9050532

Leone, P., Solimando, A. G., Fasano, R., Argentiero, A., Malerba, E., Buonavoglia, A., Lupo, L. G., De Re, V., Silvestris, N., & Racanelli, V. (2021). The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment. Vaccines, 9(5), 532. https://doi.org/10.3390/vaccines9050532